Literature DB >> 10192206

The simultaneous treatment of inflammatory bowel diseases and associated pyoderma gangrenosum with oral cyclosporin A.

G L Capella, E Frigerio, C Fracchiolla, G Altomare.   

Abstract

Entities:  

Mesh：

Substances：

Year:  1999        PMID： 10192206     DOI： 10.1080/00365529950173140

Source DB:  PubMed          Journal:  Scand J Gastroenterol        ISSN： 0036-5521            Impact factor:   2.423


× No keyword cloud information.
  3 in total

Review 1.  Important cutaneous manifestations of inflammatory bowel disease.

Authors:  L B Trost; J K McDonnell
Journal:  Postgrad Med J       Date:  2005-09       Impact factor: 2.401

2.  Efficient Production of Murine Uterine Damage Model.

Authors:  Yoon Young Kim; Bo Bin Choi; Ji Won Lim; Yong Jin Kim; Sung Yob Kim; Seung-Yup Ku
Journal:  Tissue Eng Regen Med       Date:  2018-08-18       Impact factor: 4.169

3.  Comparison of the two most commonly used treatments for pyoderma gangrenosum: results of the STOP GAP randomised controlled trial.

Authors:  Anthony D Ormerod; Kim S Thomas; Fiona E Craig; Eleanor Mitchell; Nicola Greenlaw; John Norrie; James M Mason; Shernaz Walton; Graham A Johnston; Hywel C Williams
Journal:  BMJ       Date:  2015-06-12
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.